Clinical Trial

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, random, double blind, placebo control clinical study to evaluate the safety, tolerability pharmacokinetics and food effect of HSK55879 in healthy subjects
Trial Details
NCT Number NCT07521345
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Healhty
Enrollment 46 participants
Start Date 2026-03-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-09